DaVita HealthCare Partners (NYSE:DVA) is set to post its Q215 quarterly earnings results on Tuesday, August 4th. Analysts expect DaVita HealthCare Partners to post earnings of $0.95 per share and revenue of $3.37 billion for the quarter. Individual that are interested in registering for the company’s earnings conference call can do so using this link.

DaVita HealthCare Partners (NYSE:DVA) last announced its earnings results on Tuesday, May 5th. The company reported $0.86 earnings per share (EPS) for the quarter, hitting the analysts’ consensus estimate of $0.86. During the same quarter in the prior year, the company posted $0.85 earnings per share. The company had revenue of $3.29 billion for the quarter, compared to the consensus estimate of $3.25 billion. The company’s revenue for the quarter was up 8.1% compared to the same quarter last year. On average, analysts expect DaVita HealthCare Partners to post $3.77 EPS for the current fiscal year and $4.09 EPS for the next fiscal year.

DaVita HealthCare Partners (NYSE:DVA) opened at 79.03 on Friday. The company’s 50-day moving average price is $80.02 and its 200 day moving average price is $79.70. The company has a market capitalization of $16.99 billion and a price-to-earnings ratio of 39.95. DaVita HealthCare Partners has a 12 month low of $70.85 and a 12 month high of $85.17.

DVA has been the topic of several recent analyst reports. Vetr cut shares of DaVita HealthCare Partners from a “strong-buy” rating to a “buy” rating and set a $88.97 target price for the company. in a research note on Monday, July 13th. Sanford C. Bernstein reissued a “market perform” rating and issued a $80.00 price objective on shares of DaVita HealthCare Partners in a research note on Tuesday, May 12th. Piper Jaffray lifted their price target on shares of DaVita HealthCare Partners from $87.00 to $88.00 and gave the stock a “buy” rating in a research note on Monday, May 11th. Susquehanna reiterated a “neutral” rating and set a $82.00 price objective (up previously from $75.00) on shares of DaVita HealthCare Partners in a report on Saturday, May 9th. Finally, Zacks upgraded shares of DaVita HealthCare Partners from a “hold” rating to a “buy” rating and set a $92.00 price target for the company in a report on Friday, May 8th. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The stock presently has a consensus rating of “Buy” and an average price target of $85.44.

In other DaVita HealthCare Partners news, COO Michael David Staffieri sold 9,050 shares of the company’s stock in a transaction on Thursday, May 28th. The shares were sold at an average price of $84.07, for a total transaction of $760,833.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Chairman Robert J. Margolis sold 31,400 shares of the company’s stock in a transaction on Thursday, June 4th. The stock was sold at an average price of $83.39, for a total transaction of $2,618,446.00. The disclosure for this sale can be found here.

DaVita HealthCare Partners Inc. consists of two divisions, Kidney Care and HealthCare Partners (NYSE:DVA). Kidney Care is a provider of dialysis services in the United States, treating patients with chronic kidney failure and end stage renal disease (ESRD). Kidney Care division develops innovative clinical care, offers integrated treatment plans, personalized care teams and health-management services. As of December 31, 2014, we provided dialysis and administrative services in the U.S. through a network of 2,179 outpatient dialysis centers in 46 states and the District of Columbia, serving a total of approximately 173,000 patients. HealthCare Partners division is a patient- and physician-focused integrated health care delivery and management company. HealthCare Partners manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, Florida and New Mexico. As of December 2014, HealthCare Partners had approximately 837,000 members under its care.

Receive News & Ratings for DaVita HealthCare Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DaVita HealthCare Partners and related companies with MarketBeat.com's FREE daily email newsletter.

...